| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 903,297 | 1,035,737 | 1,039,671 | | Cost of Revenue | 386,793 | 410,799 | 414,915 | | | Gross Profit | 516,504 | 624,938 | 624,756 | | | Operating Expenses | | Research Development | 115,524 | 120,864 | 113,698 | | Selling General and Administrative | 161,218 | 175,646 | 163,247 | | Non Recurring | 6,434 | 26,763 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 233,328 | 301,665 | 347,811 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 28,191 | 57,286 | 58,695 | | Earnings Before Interest And Taxes | 261,519 | 358,951 | 406,506 | | Interest Expense | 24,269 | 7,966 | 5,416 | | Income Before Tax | 237,250 | 350,985 | 401,090 | | Income Tax Expense | (11,570) | 53,237 | 44,061 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 248,820 | 297,748 | 357,029 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 248,820 | 297,748 | 357,029 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $248,820 | $297,748 | $357,029 |
|
1.48% Nasdaq 
Income Statement
